POS-797 Neoplastic complications requiring conversion to sirolimus in kidney transplant recipients: multicentric Tunisian study

N. THABET, A. Azzabi,W. Sahtout, N. Ben Aicha, R. Boukadida,A. Fradi,S. Mrabet, D. Zellama, Y. Guedri,A. Achour

Kidney International Reports(2022)

引用 0|浏览0
暂无评分
摘要
Transplant patients should be considered at high risk for the development of de novo post-transplant neoplasia. Several studies demonstrate a significant increase in cancer incidence rate after transplantation, although with a wide variability.
更多
查看译文
关键词
sirolimus,kidney transplant recipients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要